Porcine parvovirus (PPV) is a DNA virus that causes reproductive failure in gilts and sows, resulting in embryonic and fetal losses worldwide. Epitope mapping of PPV is important for developing new vaccines. In this study, we used spot synthesis analysis for epitope mapping of the capsid proteins of PPV (NADL-2 strain) and correlated the findings with predictive data from immunoinformatics. The virus was exposed to three conditions prior to inoculation in pigs: native (untreated), high hydrostatic pressure 
Introduction
Porcine parvovirus (PPV), or Ungulate Protoparvovirus 1 as proposed by Cotmore et al. 1 , is a 25-nm diameter, non-enveloped icosahedral virus that contains 5 kb of negative sense, single-strand DNA (ssDNA) comprising two large open reading frames (ORFs) in its genome. ORF1 codes for the nonstructural proteins NS1, NS2 and NS3, and ORF2 codes for the structural proteins VP1, VP2 and VP3 2 .
VP1 and VP2 capsid proteins are the result of an alternative splicing of the same gene and VP3 itself is formed by proteolytic cleavage of VP2. These structural proteins are responsible for the immunogenic properties of PPV 3 . PPV infects pregnant gilts and sows, causing reproductive failure characterized by embryonic and fetal death, mummification and stillbirths, with delayed return to oestrus 4 . The resulting reduction in reproductive capacity can significantly decrease pork production 5 .
PPV is prevalent in the pig population and highly stable in the environment, which make it difficult to establish and keep breeding populations free of the virus.
Based on this, it is important to maintain herd immunity against PPV 4 . The most widely used approach for maintaining immunity is regular vaccination of breeding females. Two main strains of PPV have been identified, based on pathogenicity:
NADL-2 (non-pathogenic) and Kresse (pathogenic), although sequence analysis of recent isolates suggests active evolution of PPV 6 . The vaccines commercially available since the 1980s are based on a chemically-inactivated NADL-2 strain. 3 The development of vaccines is important for controlling diseases such as reproductive failure caused by PPV. In this context, essential considerations should include viral diversity, protective immunity and population coverage as key factors, all of which pose special challenges to this ever-expanding field 7, 8 . One well-known approach in vaccine production is the use of inactivated viral preparations 9, 10 . In recent years, the use of high hydrostatic pressure (HHP) has become an increasingly popular non-thermal method of inactivation [11] [12] [13] . This approach has been successfully used to inactivate several viruses and represents a promising alternative to vaccine development 14 . Several studies have demonstrated that pressure can result in virus inactivation while preserving immunogenic properties. In addition, HHP is a technology free of chemicals that is safe and capable of inducing strong humoral and cellular immune responses. In this study, we used a combination of in silico and in vivo approaches to examine the immune responses to different HHP-PPV formulations that were then compared with a commercial vaccine produced using chemically-inactivated virus.
Material and methods

Virus preparation
The NADL-2 strain of PPV was cultured in SK6 cells as previously described 15 . Supernatants of cell cultures were separated and purified by CaCl2 precipitation followed by gradient ultracentrifugation, as previously described 16 . Fractions with hemagglutinating activity were dialyzed for 16 h at 4 °C against a Tris-EDTA buffer, pH 8.0 17 . The virus was titrated in SK-6 cells by serial dilutions in 96 well-plates and the cells were then screened for a cytopathic effect at 72 h post-infection. The test was considered positive when cytopathic effects were observed in >75% of the cells.
Samples containing 1x10 4.5 TCID50/mL were aliquoted and subjected to HHP. Vaccine aliquots and viral preparations were normalized to avoid an antigen-concentration effect 18 .
Briefly, virus aliquots were subjected to two treatments: one at 300 MPa for 1 h at 25 °C and another at 300 MPa at -18 °C, both immersed in 0.1 M Tris-HCl, pH 7.4.
The equipment used to treat the samples consisted of a pressure generator device (model HP ISS) coupled to a pressure cell, as previously described 19 . The freezing point (i.e., -19 °C) for these conditions was determined to be lower in previous studies by our group and (NC) (negative control). Pigs were vaccinated intramuscularly on day 0 (D0), D14, D28 and D38 according to each HHP protocol, as previously described 50 . At necropsy following euthanasia (D72), samples of lung, heart, liver, spleen, kidney and mesenteric lymph node were collected and stored at -70 °C until analyzed by nested-PCR. Pigs in the NC group received only saline solution. On D51, all pigs were challenged intranasally with a reference strain of PPV NADL-2, as previously described 21 . Serum samples were collected prior to each vaccination or challenge (D0, D14, D28, D38 and D51), as well as on D58, D65 and D72. On the last day of the experiment, a post-mortem examination was done and samples of lung, heart, liver, spleen, kidney and mesenteric lymph node were collected and stored at -70°C until analyzed by nested-PCR.
Detection of DNA and anti-PPV antibodies
Viral DNA was extracted from pig tissues using DNeasy Blood & Tissue kits (Qiagen) and subjected to nested-PCR for PPV detection, as previously described 22 .
Pig serum samples were tested for anti-PPV antibodies by an HI test 23 .
Spot synthesis
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The peptides were synthesized based on the amino acid sequence of VP1 from PPV NADL-2 strain (GenBank, accession no. NC 001718) with 12 overlapping peptides and an offset of four peptides. The membrane used for spot synthesis was prepared with Fmoc (9-flurorenylmethoxycarbonyl) chemistry 24, 25 on a PEG-derived cellulose membrane with the addition of a C-terminal anchor of β-Ala residues and hexadecapeptides at the N-terminal. All serum samples from D0, D28, D58 and D72 (representing, respectively, the basal serum condition prior to any intervention, the antibody response against the vaccine, the challenge with the reference strain and 21 days after the challenge) were screened for antibodies. An anti-swine IgG-Fc secondary antibody conjugated with alkaline phosphatase (Jackson ImmunoResearch Europe Ltd.) was used to assess epitope recognition in the peptide arrays and downstream procedures were done as previously described 25 . The membrane was subsequently scanned at 1200 d.p.i. with a Print Scan Copier (HP Photosmart) and the software package "Totallab Quant-Array Analysis" was used to quantify the spots based on the intensity of the reaction relative to the background intensity.
Linear and conformational epitope prediction
The complete primary sequence of the capsid protein of the reference strain 
Molecular dynamics 6
The crystallized structure of the VP2 protein (PDB code 1k3v) was downloaded from the Protein Data Bank. Molecular dynamics simulations were done with the GROMACS software (v. 5. nm was assumed. The CHARMM22 force field was applied for 1k3v and chloride ions and the TIP3P water model were selected for the nvt and npt equilibration protocols.
The electrostatic interactions were calculated by using the particle mesh Ewald (PME) method with a cut-off distance of 13.0 Ǻ for the van der Waals interactions and the electrostatic interactions in the real space of the PME method. The temperatures and pressures were selected using the Nosé-Hoover Langevin piston pressure control based on the Nosé-Hoover thermostat and the Langevin piston method. To simulate the experimental conditions the equilibration systems were normalized to 300 K at atmospheric pressure followed by variations in the nvt and npt protocols to achieve the desired HHP conditions, i.e., 350 MPa at 27 °C and -18 °C. Production runs for each condition were done for 20 ns and the outputs analyzed for structural parameters such as root mean square deviations (RMSD), root mean square fluctuations (RMSF), radius of gyration (Rg), secondary structure fluctuations and also for the complete system, such as pressure, temperature and energy variations.
Plots were generated with the Grace software package (http://plasmagate.weizmann.ac.il/Grace/) and trajectory analyses were done using the VMD package 31 as well as the built-in analysis packages present in GROMACS
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. Table 1 shows the detection of PPV DNA in different tissues. Groups N and NC were PPV-positive in spleen, liver, lymph node and lung. Group V was positive only in lymph node and kidney. Both HHP groups (P and P-18) were positive in spleen and liver, whereas lung positivity was identified in group P and in lymph node in group P-18. No viral DNA was detected in heart samples of any group.
Results
PPV DNA and antibody detection
No pigs presented anti-PPV antibodies at the beginning of the experiment (D0). By D14 after the first vaccination, low titer anti-PPV antibodies started to be detected. Pigs inoculated with HHP (groups P and P-18) had higher antibody titers than the pigs vaccinated with reference strain NADL-2. As expected, by D72 after the PPV challenge, all pigs seroconverted, with titers varying from 1024 to 2048.
Epitope mapping
A schematic representation of the membrane is depicted in Figure 1A , with the positive spots highlighted in Figure 1B There was a predominance of red and yellow regions in several conditions, indicating that the initial positivity in a given region frequently did not persist after challenge. In addition, spots that were positive after challenge (sample 8) were not preceded by positive epitope mapping in initial inoculations.
Pigs from group N showed no significant reaction on D28, except for sites 7
and 13 that correspond to amino acid residues 197-216 and 493-516, respectively. In general, a higher number of sites was induced and recognized in group P than in group N, but this number was lower than in group V. Sites 1, 4, 6, 13 and 18 present in group P were also found in samples 3 and 6 of group V that had been inoculated intramuscularly. Sites 1 and 13 were also detected in group N. At the last sample collected (D72), the native form showed more antigenic sites compared with groups P and V (Table 1S and Figure 1C ). Site 1 showed the highest frequency of positive spots at D28, D58 and D72 in groups N, P and V (Table 1S and Figure 1C ).
In group P-18, there was an increase in the number of positive spots ( Figure   1C ). This situation was similar to group N, but the mapped response was higher when P-18 was compared to groups P, V and NC. Group P-18 pigs showed positive antibody responses earlier than the other treatments and included sites 1, 3, 4, 6, 12, 18, 19 and 20 ( Figure 1C ). This was the only in which sites 5 (aa 101-116; 109-124) 7 (aa 209-224) and 11 (aa 429-444) were activated at D72.
Bioinformatic analysis
A combination of immunoinformatic tools and molecular dynamics simulations was used to understand the molecular recognition of the VP1-VP2 capsid proteins based on the epitope mapping results described above. By using the reference sequence of NADL-2 strain, in silico predictions identified sites with a high probability of being antigens. Since this method does not evaluate tertiary structures and is based on a sliding window to produce propensity scores, we identified six regions out of the 24 predictions that overlapped with the results for group N. simulations. As a result, the P simulation narrowed the amplitude variation per atom, thereby collapsing the flexible regions and limiting the overall variation to 0.01 nm.
Furthermore, the P-18 simulation produced a more rigid configuration with no fluctuations >0.05 nm on all atoms, in agreement with the other parameters (total volume, total energy and Rg). Interestingly, the area per residue over the trajectory increased substantially in the group P and P-18 simulations (SF-2). Moreover, the number of contacts maintained between residues decreased substantially when groups P and P-18 were compared with control group N (SF-2).
Discussion
Epitope mapping strategies have been extensively applied to key pathogens and the results provided by this approach have important applications in public health, as well as in animal safety and welfare [32] [33] [34] [35] [36] . There are ongoing efforts to identify the key epitopes on the VP1-VP2 capsid proteins of PPV through distinct strategies for mapping. A study in which pepscan was used to synthesize 24 different peptides directed towards antigenic sites detected nine such sites and posited that those found in the N-terminal region were neutralizing epitopes 37 . Xie et al. .
Antibodies that bound to a region composed of amino acids 497-516 were seen soon after the second inoculation and the titers (inferred from the intensity of the phosphatase reactions) were maintained throughout the experiment. The immunodominant regions in VP2 belong to the loops and other regions in the N-and C-terminals 37, 42, 43 . As shown in Figure 2B Although the capsid proteins were deemed to be under near-neutral selection, a few key amino acids were found to be variable (aa 215, 228, 383, 414, 419 and 436), with most of them located in surface loops 43, 44 . Zeeuw et al. 45 have previously
shown that the strain switch from avirulent (143a) to virulent (27a) might depend directly on mutations of VP2 residues 378 and 383. As expected, surface amino acids in the VP2 configuration are hydrophilic and contain most of the mutations identified by Ren et al. 46 , who also found this protein to be under negative selection.
Antibody responses against overlapping peptides of VP1 were not detected until late time points, precisely after the viral challenge, when amino acids 5 through 96 produced significant binding, thereby reinforcing previous findings regarding the Nterminal immunogenicity of PPV VP1 14, 51 . HHP allows the production of inactivated vaccines that are free of The signal intensity of the positive spots shown in Figure 1C , based on serum samples 3 and 6, and the post-challenge sample (8) , was used to construct epitope maps of PPV. The data were normalized relative to the maximum intensity for each experimental condition. The threshold was considered 40% of maximum intensity.
The models on the right show the crystallographic structure of VP2 protein (PDB entry 1k3v) with positivity indicated as yellow for sample 3 and/or 6, red for sample 8, and orange for positivity in both 3 and/or 6 and 8. 
